CIK 0001651561
TRHC Tabula Rasa HealthCare, Inc.
Insider trading from SEC Form 4. Last filing Nov 14, 2023.
In brief
Tabula Rasa HealthCare, Inc. (TRHC) has 13 SEC Form 4 filings on file from 13 insiders, the latest filed on Nov 14, 2023. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Signals
Open-market buys and sells at Tabula Rasa HealthCare, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
Every row filed, 50 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | Dennis Helling director | DDisposition to issuer Common Stock | -82,676 | - | - | 29,433 | Nov 14, 2023 |
| Nov 3, 2023 | Ronald Paul Mitchell director | DDisposition to issuer Common Stock | -17,896 | - | - | 61,436 | Nov 14, 2023 |
| Nov 3, 2023 | Michael J. Purcell director | DDisposition to issuer Common Stock | -88,514 | - | - | 50,808 | Nov 14, 2023 |
| Nov 3, 2023 | Samira Beckwith director | DDisposition to issuer Common Stock | -62,658 | - | - | 25,641 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Common Stock | -8,645 | - | - | 14,310 | Nov 14, 2023 |
| Nov 3, 2023 | Pamela Schweitzer director | DDisposition to issuer Common Stock | -53,579 | - | - | 25,641 | Nov 14, 2023 |
| Nov 3, 2023 | Indaba Capital Management, L.P. director, owner | DDisposition to issuer Common Stockindirect: See Footnotes | -6,599,966 | $10.50 | $69M | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Common Stock | -249,477 | - | - | 517,834 | Nov 14, 2023 |
| Nov 3, 2023 | Jonathan David Schwartz director | DDisposition to issuer Common Stock | -17,582 | - | - | 60,806 | Nov 14, 2023 |
| Nov 3, 2023 | Kathrine O'Brien director | DDisposition to issuer Common Stock | -20,879 | - | - | 75,810 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Common Stock | -193,208 | - | - | 393,776 | Nov 14, 2023 |
| Nov 3, 2023 | Thomas Cancro CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Stock | -61,500 | - | - | 242,592 | Nov 14, 2023 |
| Nov 3, 2023 | Richard W. Rew II CHIEF LEGAL OFFICER, SECRETARY | DDisposition to issuer Common Stock | -25,463 | - | - | 38,194 | Nov 14, 2023 |
| Nov 3, 2023 | Richard W. Rew II CHIEF LEGAL OFFICER, SECRETARY | DDisposition to issuer Common Stock | -38,194 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Dennis Helling director | DDisposition to issuer Common Stock | -3,792 | - | - | 25,641 | Nov 14, 2023 |
| Nov 6, 2023 | Indaba Capital Management, L.P. director, owner | SOpen-market sale 1.75% Convertible Senior Subordinated Notes due 2026derivativeindirect: See Footnotes | -67,500,000 | $67,243,500.00 | $4538936B | 317,785 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Common Stock | -55,556 | - | - | 462,278 | Nov 14, 2023 |
| Nov 3, 2023 | Ronald Paul Mitchell director | DDisposition to issuer Common Stock | -61,436 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Kathrine O'Brien director | DDisposition to issuer Common Stock | -50,169 | - | - | 25,641 | Nov 14, 2023 |
| Nov 3, 2023 | Michael J. Purcell director | DDisposition to issuer Common Stock | -50,808 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Jonathan David Schwartz director | DDisposition to issuer Common Stock | -60,806 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Pamela Schweitzer director | DDisposition to issuer Common Stock | -25,641 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Thomas Cancro CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Stock | -37,037 | - | - | 205,555 | Nov 14, 2023 |
| Nov 3, 2023 | Samira Beckwith director | DDisposition to issuer Common Stock | -25,641 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Common Stock | -12,960 | - | - | 1,350 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Common Stock | -41,667 | - | - | 352,109 | Nov 14, 2023 |
| Nov 3, 2023 | Dennis Helling director | DDisposition to issuer Common Stock | -25,641 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Kathrine O'Brien director | DDisposition to issuer Common Stock | -25,641 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Common Stock | -169,570 | - | - | 292,708 | Nov 14, 2023 |
| Nov 3, 2023 | Thomas Cancro CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Stock | -150,000 | - | - | 55,555 | Nov 14, 2023 |
| Nov 3, 2023 | Samira Beckwith director | DDisposition to issuer Stock Option (Right to Buy)derivative | -257 | $4.68 | $1,203 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Pamela Schweitzer director | DDisposition to issuer Common Stockindirect: By Schweitzer Family Trust | -9,784 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Common Stock | -130,234 | - | - | 221,875 | Nov 14, 2023 |
| Nov 7, 2023 | Indaba Capital Management, L.P. director, owner | SOpen-market sale 1.75% Convertible Senior Subordinated Notes due 2026derivativeindirect: See Footnotes | -22,228,000 | $22,145,756.00 | $492256B | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Common Stock | -1,350 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,250 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Dennis Helling director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,369 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Thomas Cancro CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Stock | -55,555 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Common Stock | -292,708 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Common Stock | -221,875 | - | - | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,650 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -21,350 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,077 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -723 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,850 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Brian W Adams CHIEF EXECUTIVE OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -38,270 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Anthony Bruno CHIEF ACCOUNTING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -527 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,077 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 3, 2023 | Michael Greenhalgh CHIEF OPERATING OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,770 | $0.00 | $0 | 0 | Nov 14, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Brian W AdamsCHIEF EXECUTIVE OFFICER
- Samira Beckwithdirector
- Michael Anthony BrunoCHIEF ACCOUNTING OFFICER
- Thomas CancroCHIEF FINANCIAL OFFICER
- Michael GreenhalghCHIEF OPERATING OFFICER
- Dennis Hellingdirector
- Indaba Capital Management, L.P.director, owner
- Ronald Paul Mitchelldirector
- Kathrine O'Briendirector
- Michael J. Purcelldirector
- Richard W. Rew IICHIEF LEGAL OFFICER, SECRETARY
- Jonathan David Schwartzofficer, director
- Pamela Schweitzerdirector
Questions about TRHC
Answered from the filings on this page, as of the latest one.
Are insiders buying TRHC?
No. In the last 90 days no insider at Tabula Rasa HealthCare, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade TRHC on the open market?
No open-market trade has been scored at Tabula Rasa HealthCare, Inc.. The latest Form 4 on file was filed on Nov 14, 2023 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Tabula Rasa HealthCare, Inc.?
13 people have filed a Form 4 at Tabula Rasa HealthCare, Inc., among them Brian W Adams (CHIEF EXECUTIVE OFFICER), Samira Beckwith (director), Michael Anthony Bruno (CHIEF ACCOUNTING OFFICER). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.